Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression

Molecular Biology and Evolution

Volumn 20, Issue 8, 2003, Pages 1318-1325

  Williamson, Scott ^a  

^a NONE

Author keywords

Adaptation rate; HIV evolution; Positive selection

Indexed keywords

EPITOPE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTATION; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; ENVELOPE GENE; EVOLUTION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SYMPTOMATOLOGY; VIRAL GENETICS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0041571679     PISSN: 07374038     EISSN: None     Source Type: Journal    
DOI: 10.1093/molbev/msg144     Document Type: Article

References (44)

1. Bonhoeffer, S., E. C. Holmes, and M. A. Nowak. 1995. Causes of HIV diversity. Nature 376:125.
2. Bustamante, C. D., J. Wakeley, S. A. Sawyer, and D. L. Hartl. 2001. Directional selection and the site-frequency spectrum. Genetics 159:1779-1788.
3. Clark, S. J., M. S. Saag, W. D. Decker, S. Cambell-Hill, J. L. Roberson, P. J. Veldkamp, J. C. Kappes, B. H. Hahn, and G. M. Shaw. 1991. High titers of cytopathic virus in plasma of patients with syptomatic primary HIV-1 infection. N. Engl. J. Med. 324:954-960.
4. Fenoglio, D., G. Li Para, L. Lozzi et al. (11 co-authors). 2000. Natural analogue peptides of an HIV-1 gp120 T-helper epitope antagonize response of gp120-specific human CD4 T-cell clones. J. Acquir. Immune Defic. Syndr. 23:1-7.
5. Fu, Y.-X. 2001. Estimating mutation rate and generation time from longitudinal samples of DNA sequences. Mol. Biol. Evol. 18:620-626.
6. Ganeshan, S., R. E. Dickover, B. T. M. Korber, Y. J. Bryson, and S. M. Wolinsky. 1997. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J. Virol. 71:663-677.
7. Gillespie, J. H. 2000. Genetic drift in an infinite population: the pseudohitchhiking model. Genetics 155:909-919.
8. Goudsmit, J., C. Debrouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. Wolff, C. J. Gibbs, and D. C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85:4478-4482.
9. Hey, J., and J. Wakeley. 1997. A coalescent estimator of the population recombination rate. Genetics 145:833-846.
10. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
11. Holmes, E. C., L. Q. Zhang, P. Simmonds, C. A. Ludlam, and A. J. Brown. 1992. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc. Natl. Acad. Sci. USA 89:4835-4839.
12. Kelly, J. K. 1994. An application of population genetic theory to synonymous gene sequence evolution in the human immunodeficiency virus (HIV). Genet. Res. 64:1-9.
13. Kelly, J. K., S. Williamson, M. E. Orive, M. S. Smith, and R. D. Holt. 2003. Linking ecological and genetic models of intrahost viral dynamics. I. Infection of multiple cell types. Am. Nat. (in press).
14. Markham, R. B., W.-C. Wang, A. E. Weisstein et al. (11 co-authors). 1998. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc. Natl. Acad. Sci. USA 95:12568-12573.
15. Maynard Smith, J., and J. Haigh. 1974. The hitch-hiking effect of a favourable gene. Genet. Res. 23:23-35.
16. McDonald, J. H., and M. Kreitman. 1991. Adaptive protein evolution at the Adh locus in Drosophila. Nature 351:652-654.
17. Modrow, S., B. H. Hahn, G. M. Shaw, R. C. Gallo, F. Wong-Staal, and H. Wolf. 1987. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61:570-578.
18. Müller, V., J. F. Vigueras-Gómez, and S. Bonhoeffer. 2002. Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection. J. Virol. 76:963-8965.
19. n in the HIV-1 env gene. Mol. Biol. Evol. 16:711-714.
20. Nielsen, R., and Z. Yang. 1998. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936.
21. Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. Wolfs, J. Goudsmit, and R. M. May. 1991. Antigenic diversity thresholds and the development of AIDS. Science 254:963-969.
22. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-335.
23. Perelson, A. S., A. U. NeuMann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
24. Pierson, T., J. McArthur, and R. F. Siliciano. 2000. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18:665-708.
25. Rice, J. A. 1987. Mathematical statistics and data analysis. Wadsworth, Pacific Grove, Calif.
26. Rodrigo, A. G., E. G. Shaper, E. L. Delwart, A. K. Iversen, M. V. Gallo, J. Brojatsch, M. S. Hirsch, B. D. Walker, and J. I. Mullins. 1999. Coalescent estimates of HIV-1 generation time in vivo. Proc. Natl. Acad. Sci. USA 96:2187-2191.
27. Ross, H. A., and A. G. Rodrigo. 2002. Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J. Virol. 76:11715-11720.
28. Sawyer, S. A., and D. L. Hartl. 1992. Population genetics of polymorphism and divergence. Genetics 132:1161-1176.
29. Seo, T.-K, J. L. Thome, M. Hasegawa, and H. Kishino. 2002. Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. Genetics 160:1283-1293.
30. Shankarappa, R., J. B. Margolick, S. J. Gange et al. (12 co-authors). 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
31. Smith, N. G. C., and A. Eyre-Walker. 2002. Adaptive protein evolution in Drosophila. Nature 415:1022-1024.
32. Strunnikova, N., S. C. Ray, C. Lancioni, M. Nguyen, and R. P. Viscidi. 1998. Evolution of human immunodeficiency virus type 1 in relation to disease progression in children. J. Hum. Virol. 1:224-239.
33. Strunnikova, N., S. C. Ray, R. A. Livingston, E. Rubalcaba, and R. P. Viscidi. 1995. Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. J. Virol. 69:7548-7558.
34. Tersmette, M., R. A. Gruters, F. de Wolf, R. E. de Goede, J. M. Lange, P. T. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
35. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 24:4876-4882.
36. Tsubota, H., C. I. Lord, D. I. Watkins, C. Morimoto, and N. L. Letvin. 1989. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1434.
37. Viscidi, R. P. 1999. HIV evolution and disease progression via longitudinal studies. Pp. 346-389 in K. A. Crandall, ed. The evolution of HIV. John Hopkins, Baltimore.
38. Walker, C. M., D. J. Moody, D. P. Stites, and J. A. Levy. 1986. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
39. Wodarz, D., P. Klenerman, and M. A. Nowak. 1998. Dynamics of cytotoxic T-lymphocyte exhaustion. Proc. R. Soc. Lond. B Biol. Sci. 265:191-203.
40. Wolfs, T. F., J. J. de Jong, H. Van den Berg, J. M. Tijnagel, W. J. Krone, and J. Goudsmit. 1990. Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host-dependent, rapid, and continuous. Proc. Natl. Acad. Sci. USA 87:9938-9942.
41. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann et al. (11 co-authors). 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
42. Wolinsky, S. M., and G. H. Learn. 1999. Levels of diversity within and among host individuals. Pp. 275-314 in K. A. Crandall, ed. The evolution of HIV. John Hopkins, Baltimore.
43. Yamaguchi-Kabata, Y., and T. Gojobori 2000. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J. Virol. 74:4335-4350.
44. Zanotto, P. M. A., E. G. Kallas, R. F. de Souza, and E. C. Holmes. 1999. Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 153:1077-1089.